ArticleBrazilian journal of physical therapy2026
Cardiac rehabilitation coverage and program characteristics in Latin America and the Caribbean: Comparisons from the ICCPR's 2025 Global Audit Update.
Article in Brazilian journal of physical therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
35 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionCardiac rehabilitation (CR) is a proven, cost-effective secondary prevention intervention. Latin America and the Caribbean (LAC) bears a disproportionate burden of cardiovascular diseases yet limited CR availability. This Global Audit aimed to characterize CR coverage and delivery (access, staffing, core components, dose) in LAC, comparing findings with ICCPR's 2016 Audit and current global data.
methodsBetween May-September 2025, any phase II CR programs in all 35 LAC countries were identified through local Societies and surveyed (REDCap). Ischemic heart disease incidence was extracted from the Global Burden of Disease study 2023 estimates to reflect CR need, and juxtaposed with annual program volume data.
resultsCR was available in 25 (71.4%) LAC countries, comprising 337 programs-a 32.2% increase from 2016. Responses were received from 255 programs in 19 (76.5%) countries with CR. Based on need, the total estimated service shortfall across the region was 635,945 patients/year, with a median of 2.9% coverage/country. Systematic CR referral was infrequent (6.3%), except in Chile. Fewer patients were paying out-of-pocket, but were paying more where they were. Using purchasing power parity, delivery costs per program were significantly lower in LAC than globally (p<.001). Multidisciplinary teams comprised 5 (median; P25-P75=3.8-7.0) members. Programs delivered 9/10 (P25-P75=7.0-10.0) core components, with patient education nearly universal, but tobacco cessation interventions-while increased from 2016-still lower than globally. Alternative model availability remained relatively unchanged from 2016 at <20%, and lower than that globally (29.5%). Total median dose was 25 sessions per supervised program, and 12/patient in alternative models.
conclusionsHigh-quality CR persists, but system-level shortfalls limit impact.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.